Lisinopril and Ogen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lisinopril (lisinopril) and Ogen (estropipate). Common drug interactions include pain in extremity among females and blood beta-d-glucan increased among males.
The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Ogen. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Lisinopril?
Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.
What is Ogen?
Ogen has active ingredients of estropipate. eHealthMe is studying from 2,553 Ogen users. Check the latest studies of Ogen.
26 people who take Lisinopril and Ogen together, and have interactions are studied.

What are the common drug interactions of Lisinopril and Ogen, by gender? *:
female:
- Pain in extremity
- Back pain
- Bone pain
- Injection site erythema (redness at injection site)
- Malaise (a feeling of general discomfort or uneasiness)
- Muscle spasms (muscle contraction)
- Nausea (feeling of having an urge to vomit)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
- Breast cancer
male:
- Blood beta-d-glucan increased
- Hypercalcaemia (elevated calcium (ca+) level in the blood)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Pneumonia
- Renal failure (kidney dysfunction)
- Renal failure acute (rapid kidney dysfunction)
- Renal failure chronic (long lasting kidney dysfunction)
What are the common drug interactions of Lisinopril and Ogen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Infection
- Melaena (the passage of black, tarry stools)
- Pain
- Weight decreased
- Breakthrough pain
- Eructation (release of gas from the digestive tract)
50-59:
- Chapped lips (cracking, fissuring, and peeling of the skin f lip)
- Diarrhoea
- Gingival swelling (gums swelling)
- Lip swelling
- Ankle fracture
- Back disorder
- Bone disorder
- Calcium deficiency (lack of calcium)
- Depression
- Exostosis (formation of new bone on the surface of a bone)
60+:
- Asthenia (weakness)
- Pain in extremity
- Breast cancer
- Chest wall pain
- Hypersensitivity
- Sensory disturbance (sense disturbance)
- Abdominal pain
- Amaurosis fugax (painless transient monocular visual loss)
- Anal cancer
- Anxiety
What are the existing conditions these people have? *
- High Blood Cholesterol: 6 people, 23.08%
- Osteoporosis (bones weak and more likely to break): 4 people, 15.38%
- Diabetes: 4 people, 15.38%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 11.54%
- Migraine (headache): 3 people, 11.54%
- Type 2 Diabetes: 2 people, 7.69%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.69%
- Pain: 2 people, 7.69%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 7.69%
- Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Lisinopril and Ogen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lisinopril (358,654 reports)
- Ogen (2,553 reports)
Browse all drug interactions of Lisinopril and Ogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lisinopril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lisinopril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ogen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
- Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on lisinopril and estropipate (the active ingredients of Lisinopril and Ogen, respectively), and Lisinopril and Ogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zofran and Paxlovid - a second ago
- Could Lidocaine cause Hepatic Enzyme Increased? - 3 seconds ago
- Could Chloramphenicol cause Diplopia? - 6 seconds ago
- Drug interactions of Flagyl and Coartem - 36 seconds ago
- Could Chantix cause Acute Coronary Syndrome? - 42 seconds ago
- Could Hyzaar cause Skin Infection? - a minute ago
- Could Trileptal cause Blood Amylase Increased? - a minute ago
- Drug interactions of Nexavar and Metoprolol Tartrate - a minute ago
- Could Ibrance cause Infusion Site Pain? - a minute ago
- Drug interactions of Glipizide and Fosinopril Sodium - a minute ago